Pascal Desmazeau

USPTO Granted Patents = 17 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 26(Granted Patents)

Location History:

Tigery, FR (2003 - 2011)
Paris, FR (2013)

Company Filing History:

Sanofi-a Ventis Deutschland Gmbh

Years Active: 2003-2013

Loading Chart...

17 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8367715 - Pyrazole derivatives, preparation thereof, and therapeutic use thereof (2013-02-05),

2. 7947706 - Substituted pyrrolopyridines, compositions containing them, manufacturing process therefor and use thereof (2011-05-24),

3. 7638521 - 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them (2009-12-29),

4. 7592365 - Substituted pyrroles, compositions containing same, method for making same and use thereof (2009-09-22),

5. 7531663 - 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them (2009-05-12),

6. 7517902 - Substituted indazoles, compositions containing the same, and the preparation and use thereof (2009-04-14),

7. 7232799 - Streptogramin derivatives and compositions thereof (2007-06-19),

8. 7230007 - Derivatives of 3-(Guanidinocarbonyl) heterocycle, methods of preparation and intermediates thereof, their use as medicaments, and pharmaceutical compositions therefrom (2007-06-12),

9. 7166594 - Streptogramin derivatives, their preparation and compositions containing them (2007-01-23),

10. 7078414 - Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them (2006-07-18),

11. 7019110 - Streptogramin derivatives, preparation method and compositions containing same (2006-03-28),

12. 6962901 - Streptogramin derivatives, their preparation and compositions which contain them (2005-11-08),

13. 6958383 - Streptogramin derivatives, preparation method and compositions containing same (2005-10-25),

14. 6699897 - Streptogramin derivatives, their preparation and compositions which contain them (2004-03-02),

15. 6596717 - Streptogramin derivatives, their preparation and compositions which contain them (2003-07-22),

Title: Pascal Desmazeau: Pioneering Innovator from Tigery, France

Introduction

Pascal Desmazeau, a prolific inventor hailing from Tigery, France, is renowned for his groundbreaking work in the field of pharmaceuticals. With an impressive portfolio of 17 patents to his name, Desmazeau has significantly contributed to the advancement of medical science through his innovative research and discoveries.

Latest Patents

Desmazeau's latest patents showcase his expertise and ingenuity in developing novel pharmaceutical compounds with diverse therapeutic applications. One of his recent inventions includes pyrazole derivatives, their preparation, and therapeutic uses. These derivatives, characterized by their unique chemical structure, hold immense potential in the treatment of various medical conditions. Additionally, Desmazeau has also patented substituted pyrrolopyridines, which exhibit promising anticancer properties, making them valuable assets in the fight against cancer.

Career Highlights

Throughout his illustrious career, Pascal Desmazeau has made substantial contributions to prominent pharmaceutical companies such as Aventis Pharma S.A. and Sanofi-Aventis Deutschland GmbH. His dedication to research and innovation has not only enhanced the product portfolios of these companies but has also propelled the field of pharmaceuticals towards new horizons.

Collaborations

Desmazeau's collaborative efforts with notable coworkers, including Eric Bacque and Baptiste Ronan, have been instrumental in shaping the success of his inventions. By fostering a culture of teamwork and knowledge sharing, Desmazeau has cultivated a rich environment for innovation, where ideas flourish, and breakthroughs emerge.

Conclusion

In conclusion, Pascal Desmazeau stands as a beacon of innovation in the realm of pharmaceutical research. His relentless pursuit of excellence, coupled with his visionary approach to problem-solving, has earned him a well-deserved reputation as a trailblazer in the field. As he continues to push the boundaries of scientific discovery, the impact of his inventions is poised to resonate far and wide, ultimately improving the lives of countless individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.